NCT00558506View on ClinicalTrials.gov

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis

PHASE2UnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

December 31, 2009

Conditions

Ankylosing Spondylitis

Interventions

DRUG

abatacept

intravenously 750mg (in patients with weight of 60- 100kg)

Trial Locations (2)

12200

RECRUITING

Charité University Medicine Berlin, Campus Benjamin-Franklin, Berlin

44652

RECRUITING

Rheumazentrum Ruhrgebiet, Herne

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER